C. Crowther

发表

Approaches to Delivering RNAi Therapeutics that Target Hepatitis B Virus

A. Ely, P. Arbuthnot, C. Crowther, 2013 .

Controlling HBV replication in vivo by intravenous administration of triggered PEGylated siRNA-nanoparticles.

Yukikazu Natori, Andrew D. Miller, Michael R Jorgensen, 2009, Molecular pharmaceutics.

Mobilization of the non-conjugative IncQ plasmid RSF1010.

C. Crowther, N. Willetts, 1981, Genetical research.

Aminoglycoside-Resistant Mutation of Pseudomonas aeruginosa Defective in Cytochrome c552 and Nitrate Reductase

C. Crowther, B. Holloway, T. Nicas, 1980, Antimicrobial Agents and Chemotherapy.

Inhibition of HBV replication in vivo using helper-dependent adenovirus vectors to deliver antiviral RNA interference expression cassettes

A. Ely, P. Arbuthnot, C. Crowther, 2014, Antiviral therapy.

Inhibition of hepatitis B virus replication in vivo using lipoplexes containing altritol-modified antiviral siRNAs

Eric B. Roesch, P. Herdewijn, P. Marion, 2010, Artificial DNA, PNA & XNA.

The insertion sequence IS21 of R68.45 and the molecular basis for mobilization of the bacterial chromosome.

C. Crowther, B. Holloway, N. Willetts, 1981, Plasmid.

Novavax NVX-COV2373 triggers potent neutralization of Omicron sub-lineages

S. Madhi, V. Shinde, S. Richardson, 2022, bioRxiv.

Hepatic Delivery of Artificial Micro RNAs Using Helper-Dependent Adenoviral Vectors.

P. Arbuthnot, C. Crowther, Betty Mowa, 2016, Methods in molecular biology.

Efficient inhibition of hepatitis B virus replication in vivo, using polyethylene glycol-modified adenovirus vectors.

P. Marion, A. Ely, P. Arbuthnot, 2008 .

Inhibition of Hepatitis B Virus Replication by Helper Dependent Adenoviral Vectors Expressing Artificial Anti-HBV Pri-miRs from a Liver-Specific Promoter

A. Ely, P. Arbuthnot, C. Crowther, 2014, BioMed research international.

Recombinant Pegylated first and third generation adenovirus vectors for delivery of anti-Hepatitis B virus RNA interference effectors

C. Crowther, 2014 .

Effective inhibition of HBV replication in vivo by anti-HBx short hairpin RNAs.

P. Marion, N. Moolla, A. Ely, 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

Specific inhibition of HBV replication in vitro and in vivo with expressed long hairpin RNA.

Samantha Barichievy, A. Ely, P. Arbuthnot, 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

Efficient silencing of hepatitis B virus by helper-dependent adenovirus vector-mediated delivery of artificial antiviral primary micro RNAs.

A. Ely, P. Arbuthnot, C. Crowther, 2012, MicroRNA.

Therapeutic potential of adenoviral vectors for delivery of expressed RNAi activators

P. Arbuthnot, C. Crowther, M. B. Mowa, 2010, Expert opinion on drug delivery.

Expressed anti-HBV primary microRNA shuttles inhibit viral replication efficiently in vitro and in vivo.

A. Ely, P. Arbuthnot, C. Crowther, 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

A valine to phenylalanine mutation in the precore region of hepatitis B virus causes intracellular retention and impaired secretion of HBe‐antigen

C. Crowther, M. Kew, A. Kramvis, 2008, Hepatology research : the official journal of the Japan Society of Hepatology.

AAV-Mediated Expression of Broadly Neutralizing and Vaccine-like Antibodies Targeting the HIV-1 Envelope V2 Region

L. Morris, S. A. Abdool Karim, A. Balazs, 2019, Molecular therapy. Methods & clinical development.

Nonprogressing HIV-infected children share fundamental immunological features of nonpathogenic SIV infection

B. Walker, T. Ndung’u, P. Goulder, 2016, Science Translational Medicine.

Measuring the ability of HIV-specific antibodies to mediate trogocytosis.

L. Morris, S. Richardson, C. Crowther, 2018, Journal of immunological methods.

R Plasmids and Bacterial Chromosome Transfer

C. Crowther, B. Holloway, M. Nayudu, 1980 .

Plasmid-Chromosome Interactions in Pseudomonas Aeruginosa

D. Haas, C. Crowther, J. Watson, 1977 .

Novavax NVX-COV2373 triggers neutralization of Omicron sub-lineages

S. Madhi, V. Shinde, U. Lalloo, 2023, Scientific Reports.

Production and Immunogenicity of Soluble Plant-Produced HIV-1 Subtype C Envelope gp140 Immunogens

L. Morris, C. Crowther, E. Rybicki, 2019, Front. Plant Sci..

DODAG; a versatile new cationic lipid that mediates efficient delivery of pDNA and siRNA.

Andrew D. Miller, P. Marion, N. Kamaly, 2010, Journal of controlled release : official journal of the Controlled Release Society.

Neutralizing antibodies elicited by the Ad26.COV2.S COVID-19 vaccine show reduced activity against 501Y.V2 (B.1.351), despite protection against severe disease by this variant

H. Schuitemaker, L. Morris, P. Moore, 2021, bioRxiv.

DODAG; a versatile new cationic lipid that mediates efficient delivery of pDNA and siRNA.

Andrew D. Miller, P. Marion, N. Kamaly, 2010, Journal of controlled release : official journal of the Controlled Release Society.

799. Expressed Long Hairpin RNA Sequences Inhibit HBV Replication In Vivo without Inducing an Interferon Response

Samantha Barichievy, A. Ely, P. Arbuthnot, 2006 .

Inhibition of Hepatitis B Virus Replication by Helper Dependent Adenoviral Vectors Expressing Artificial Anti-HBV Pri-miRs from a Liver-Specific Promoter

A. Ely, P. Arbuthnot, C. Crowther, 2014, BioMed research international.

Efficient inhibition of hepatitis B virus replication in vivo, using polyethylene glycol-modified adenovirus vectors.

P. Marion, A. Ely, P. Arbuthnot, 2008, Human gene therapy.